The efficacy of topiramate in epilepsy syndromes has been proved in West syndrome, [8,9] myoclonic-astatic epilepsy, and Dravet syndrome, as well as in refractory status epilepticus.

Other epilepsy syndromes with absence attacks are usually much more difficult to treat. An overwhelming majority of children ...

Dravet syndrome, a rare form of epilepsy affecting approximately one in 15,000 babies, typically begins before the age of one. Youngsters taking part in the trial have seen dramatic changes ...

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy ...

This work was supported by the CURE Epilepsy Rare Epilepsy Partnership Award for SCN8A, co-funded by The Cute Syndrome Foundation, the National Institute of Neurological Disorders and Stroke ...

A Smyrna mom says Georgia’s aid to families dealing with Dravet syndrome, a rare form of epilepsy, is falling short of the need. Shannon Cloud, a parent of a child who suffers from Dravet, ...

Of course, retrospective studies lack the rigor of the blinded studies, [24] but they might provide useful insight into the efficacy of a new antiepileptic drug. In fact, a new antiepileptic drug ...